Cardioprotective strategies of ACEi/ARBs and beta-blockers against anthracycline-induced cardiotoxicity in pediatric cancer survivors: a systematic review. [PDF]
CardiooncologySattarpour R, Noori M.
europepmc +1 more source
Concomitant Enalapril and Spironolactone-Induced Hyperkalemia in a Pediatric Patient. [PDF]
J Pediatr Pharmacol TherRogado SM +4 more
europepmc +1 more source
Impact of sacubitril/valsartan on cardiac structure and function in post-acute myocardial infarction heart failure patients aged over 65: a single-center experience. [PDF]
Am J Transl ResYang L +9 more
europepmc +1 more source
Long-Term Safety and Effectiveness of Calcium Channel Blockers in Hypertension: A Systematic Review. [PDF]
Drug Healthc Patient SafAisyah N, Aurellia JS, Insani WN.
europepmc +1 more source
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices. [PDF]
Respir ResMahavadi P +13 more
europepmc +1 more source
Isosakuranetin ameliorates hypertension in rats induced by L-NAME. [PDF]
J Pharm Health Care SciPantan R +3 more
europepmc +1 more source
Effect of enalapril and losartan on the expression of genes involved in inflammation, fibrogenesis, and apoptosis in orbital fibroblasts of graves' ophthalmopathy. [PDF]
BMC Res NotesSanie-Jahromi F, Khademi B, Owji N.
europepmc +1 more source
ERRATUM: Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. [PDF]
J EndocrinolApaijai N +4 more
europepmc +1 more source
Angiotensin II/Angiotensin I Ratio as a New Pharmacodynamic Parameter for Population Modelling in Healthy Adults and Children with Heart Failure Treated with Enalapril. [PDF]
PharmaceuticsSteichert M +5 more
europepmc +1 more source
Beyond blood pressure: the renin-angiotensin system as an innovative driver and therapeutic target in pathological scarring. [PDF]
Front PharmacolShi BH +6 more
europepmc +1 more source